James Mullen
James Mullen is a building contractor. Browse accreditations, trade specialisms and planning-approved project history.
active
Is this your business?
Claim it free to receive enquiries from homeowners searching for contractors like you.
CF10 4DX
About James Mullen
James C. “Jim” Mullen is an American business executive. He is the executive chairman at genome editing company Editas Medicine since 2018, where he was CEO between 2021 and 2022.
Services & Trade Specialisms
Retrofit Coordinator
Trade Accreditations & Certifications
TrustMark
Licence: 2468241